ebomi
Colour theme
Sign in
Insider · CIK 0001780113

Harris Erik

CIK 0001780113 Name as filed on the most recent filing

Filed as Harris Erik (16)

19 transaction lines · from 16 filings · filed 2020-10-16 to 2026-03-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

19 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-03-02 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 10,539 disposed 22.80 240,289.20 Form 4, filing 0001193125-26-089282
2025-03-03 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 15,103 disposed 42.10 635,836.30 Form 4, filing 0000950170-25-032773
2024-03-01 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 4,768 disposed 53.76 256,327.68 Form 4, filing 0000950170-24-026629
2023-09-05 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 6,000 disposed 37.96 227,760.00 Form 4, filing 0001209191-23-048491
2023-06-19 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 305 disposed 48.20 14,701.00 Form 4, filing 0001209191-23-038885
2023-03-01 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 3,664 disposed 45.25 165,796.00 Form 4, filing 0001209191-23-016039
2022-06-19 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 295 disposed 54.78 16,160.10 Form 4, filing 0001209191-22-038774
2022-03-01 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,713 disposed 66.62 180,740.06 Form 4, filing 0001209191-22-015830
2021-10-14 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 303 disposed 81.14 24,585.42 Form 4, filing 0001209191-21-060760
2021-07-06 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 375 disposed 91.53 34,323.75 Form 4, filing 0001209191-21-045972
2021-06-21 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 572 disposed 94.96 54,317.12 Form 4, filing 0001209191-21-042812
2021-06-19 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 437 disposed 94.63 41,353.31 Form 4, filing 0001209191-21-042812
2021-05-07 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 393 disposed 113.67 44,672.31 Form 4, filing 0001209191-21-031378
2021-05-06 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 307 disposed 113.68 34,899.76 Form 4, filing 0001209191-21-031378
2021-04-20 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 396 disposed 104.28 41,294.88 Form 4, filing 0001209191-21-027881
2021-03-02 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 707 disposed 138.16 97,679.12 Form 4, filing 0001209191-21-017554
2021-03-01 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,470 disposed 138.17 341,279.90 Form 4, filing 0001209191-21-017554
2020-10-14 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 220 disposed 88.00 19,360.00 Form 4, filing 0001209191-20-055176
2020-06-03 Ultragenyx Pharmaceutical Inc.
RARE 		S, Open-market sale 2,516 disposed 74.69 187,920.04 Form 4, filing 0001209191-21-007555

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 19
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Harris Erik, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001780113

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.